PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för beauveriolide I. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

10 hits

Bibliografisk träff 2020-01-08

Genome mining and biosynthesis of the Acyl-CoA:cholesterol acyltransferase inhibitor beauveriolide I and III in Cordyceps militaris.

Wang X, Gao YL, Zhang ML, Zhang HD, Huang JZ, Li L.

J Biotechnol · journal article · DOI 10.1016/j.jbiotec.2020.01.002

Bibliografisk träff 2012-12-20

Traditional Chinese medicine application in HIV: an in silico study.

Huang HJ, Jian YR, Chen CY, Chen CY.

J Biomol Struct Dyn · research support, non-u.s. gov't; journal article · DOI 10.1080/07391102.2012.745168

Bibliografisk träff 2012-06-07

New rapid screening method for anti-aging compounds using budding yeast and identification of beauveriolide I as a potent active compound.

Nakaya S, Mizuno S, Ishigami H, Yamakawa Y, Kawagishi H, Ushimaru T.

Biosci Biotechnol Biochem · research support, non-u.s. gov't; journal article · DOI 10.1271/bbb.110872

Bibliografisk träff 2011-10-21

Conformationally restricted analog and biotin-labeled probe based on beauveriolide III.

Doi T, Muraoka T, Ohshiro T, Matsuda D, Yoshida M, Takahashi T, Omura S, Tomoda H.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2011.10.045

Bibliografisk träff 2009-05-01

The natural products beauveriolide I and III: a new class of beta-amyloid-lowering compounds.

Witter DP, Chen Y, Rogel JK, Boldt GE, Wentworth P.

Chembiochem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1002/cbic.200900139

Bibliografisk träff 2008-06-20

Synthesis and biological evaluation of a focused library of beauveriolides.

Nagai K, Doi T, Ohshiro T, Sunazuka T, Tomoda H, Takahashi T, Omura S.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2008.06.054

Bibliografisk träff 2007-09-06

Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.

Tomoda H, Doi T.

Acc Chem Res · research support, non-u.s. gov't; review; journal article · DOI 10.1021/ar700117b

Bibliografisk träff 2004-01-12

Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.

Namatame I, Tomoda H, Ishibashi S, Omura S.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; journal article · DOI 10.1073/pnas.0307757100

Bibliografisk träff 2002-12-01

Selective production of fungal beauveriolide I or III by fermentation in amino acid-supplemented media.

Namatame I, Matsuda D, Tomoda H, Yamaguchi Y, Masuma R, Kobayashi S, Omura S.

J Antibiot (Tokyo) · research support, non-u.s. gov't; journal article · DOI 10.7164/antibiotics.55.1048

Bibliografisk träff 1999-01-01

Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979.

Namatame I, Tomoda H, Si S, Yamaguchi Y, Masuma R, Omura S.

J Antibiot (Tokyo) · research support, non-u.s. gov't; journal article · DOI 10.7164/antibiotics.52.1